Optimisation and application of a T-cell antigen-specific activation assay as diagnostic and treatment-monitoring tool for tuberculosis

We demonstrated that TB-TASA could also be reliably measured in capillary blood collected <i>via</i> fingerprick from IGRA<sup>+</sup> controls and TB patients, achieving an ROC AUC of 0.96 (95% CI 0.9-1) and sensitivity and specificity of 95% and 69%, respectively. Together, these results support the continued development of TB-TASA as a potential tool for diagnosing TB and monitoring treatment responses.

Authors

Institutions

Publication Details

Journal
ERJ Open Research
Published
2025-10-23
DOI
https://doi.org/10.1183/23120541.01016-2025
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimisation and application of a T-cell antigen-specific activation assay as diagnostic and treatment-monitoring tool for tuberculosis

Stephanus T. Malherbe, Mark Hatherill, Hadn Africa, Laura E. Via et al.
ERJ Open Research
Tuberculosis Research and Epidemiology
article

Optimisation and application of a T-cell antigen-specific activation assay as diagnostic and treatment-monitoring tool for tuberculosis

Stephanus T. Malherbe, Mark Hatherill, Hadn Africa, Laura E. Via, Ray Y. Chen, Lungisa Jaxa, Clifton E. Barry, Ashley Veldsman, Gerhard Walzl, Humphrey Mulenga, Elisa Nemes, Robert John Wilkinson, Catherine Riou, Simon C. Mendelsohn, Michèle Tameris, Elizabeth Filander, Thomas J. Scriba, Munyaradzi Musvosvi, Michelle Fisher, Suzette Visagie
article en

Abstract

We demonstrated that TB-TASA could also be reliably measured in capillary blood collected <i>via</i> fingerprick from IGRA<sup>+</sup> controls and TB patients, achieving an ROC AUC of 0.96 (95% CI 0.9-1) and sensitivity and specificity of 95% and 69%, respectively. Together, these results support the continued development of TB-TASA as a potential tool for diagnosing TB and monitoring treatment responses.

ERJ Open ResearchVol. 12(2)
South African Medical Research Council (ZA), National Institutes of Health (US), University of Cape Town (ZA), Stellenbosch University (ZA), The Francis Crick Institute (GB), South African Tuberculosis Vaccine Initiative (ZA), National Institute of Allergy and Infectious Diseases (US), Wellcome Centre for Infectious Diseases Research in Africa (ZA), Imperial College London (GB)
Bill and Melinda Gates Foundation, Francis Crick Institute, UK Research and Innovation, Cancer Research UK, National Institute for Health and Care Research, Imperial College London, Imperial College Healthcare NHS Trust, South African Medical Research Council, Universiteit Stellenbosch, University of Cape Town, National Institutes of Health, Medical Research Council, National Institute of Allergy and Infectious Diseases, NHLBI Division of Intramural Research, European and Developing Countries Clinical Trials Partnership
Openalex Percentile: Top 64%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.